The discovery that tissues use electricity to expel unhealthy cells is part of a surge of renewed interest in the currents flowing through our bodies. We’re used to thinking of the brain as an ...

Optical metasurfaces, with their ultra-thin and lightweight properties, are driving the miniaturization and planarization of optical systems. However, their development from unit-cell design to system ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

GameSpot may get a commission from retail offers. Earlier this week, Netflix premiered the first season of Splinter Cell: Deathwatch, an animated show based on Tom Clancy's iconic hero Sam Fisher.

“Splinter Cell: Deathwatch” has officially been renewed for a second season at Netflix. The news comes one day after the series premiere on Oct. 14. Variety first reported that a “Splinter Cell” ...

A day after the premiere of Tom Clancy’s Splinter Cell: Deathwatch, Netflix has renewed the adult animated series for a second season. Liev Schreiber leads the voice cast of the series, the first ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.

Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...

Tristan Jurkovich began his career as a journalist in 2011. His childhood love of video games and writing fuel his passion for archiving this great medium’s history. He dabbles in every genre, but ...

Rachael Wakefield-Rann receives research funding from various government and non-government organisations. She does not work for, consult, own shares in or receive funding from any company or ...